| 1 | [SID49669839] | Active | Potency | 13.794 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation [AID489043, Type: confirmatory] | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 13.794 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation | | AID | 489043 | | BioAssay type | confirmatory | | Target | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] | | PubMed | | | Data Table |  |
|
| 2 | [SID49669839] | Active | Potency | 13.794 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation [AID489043, Type: confirmatory] | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 13.794 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation | | AID | 489043 | | BioAssay type | confirmatory | | Target | relaxin receptor 2 isoform 1 [Homo sapiens] [gi:18677729] | | PubMed | | | Data Table |  |
|
| 3 | [SID49669839] | Active | Potency | 15.4772 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation [AID489012, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 15.4772 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation | | AID | 489012 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 4 | [SID49669839] | Active | Potency | 15.4772 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation [AID489012, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 15.4772 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation | | AID | 489012 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 5 | [SID49669839] | Active | Potency | 15.8489 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 6 | [SID49669839] | Active | Potency | 15.8489 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 7 | [SID49669839] | Active | Potency | 19.4846 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation [AID492948, Type: confirmatory] | vasopressin V1b receptor [Homo sapiens] [gi:4502333] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 19.4846 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation | | AID | 492948 | | BioAssay type | confirmatory | | Target | vasopressin V1b receptor [Homo sapiens] [gi:4502333] | | PubMed | | | Data Table |  |
|
| 8 | [SID49669839] | Active | Potency | 19.4846 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation [AID492948, Type: confirmatory] | vasopressin V1b receptor [Homo sapiens] [gi:4502333] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 19.4846 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation | | AID | 492948 | | BioAssay type | confirmatory | | Target | vasopressin V1b receptor [Homo sapiens] [gi:4502333] | | PubMed | | | Data Table |  |
|
| 9 | [SID49669839] | Active | Potency | 19.4846 | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation [AID492948, Type: confirmatory] | vasopressin V1b receptor [Homo sapiens] [gi:4502333] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 19.4846 [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation | | AID | 492948 | | BioAssay type | confirmatory | | Target | vasopressin V1b receptor [Homo sapiens] [gi:4502333] | | PubMed | | | Data Table |  |
|
| 10 | [SID49669839] | Active | Potency | 31.6228 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 11 | [SID49669839] | Active | Potency | 89.1251 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Active | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 12 | [SID49669839] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID49669839] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID49669839] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 15 | [SID49669839] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 16 | [SID49669839] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 17 | [SID49669839] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 18 | [SID49669839] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 19 | [SID49669839] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 20 | [SID49669839] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 21 | [SID49669839] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 22 | [SID49669839] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 23 | [SID49669839] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers [AID493056, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers | | AID | 493056 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 24 | [SID49669839] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. [AID493084, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. | | AID | 493084 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 25 | [SID49669839] | Inactive | Potency | | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 26 | [SID49669839] | Inactive | Potency | | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 [AID493005, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101 | | AID | 493005 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 27 | [SID49669839] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 28 | [SID49669839] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 29 | [SID49669839] | Inactive | | | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504810, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504810 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 30 | [SID49669839] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 31 | [SID49669839] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 32 | [SID49669839] | Inactive | | | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign [AID504812, Type: Literature] | TSHR protein [Homo sapiens] [gi:118341367] |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | | AID | 504812 | | BioAssay type | Literature | | Target | TSHR protein [Homo sapiens] [gi:118341367] | | PubMed | 20427476 | | Data Table |  |
|
| 33 | [SID49669839] | Inactive | IC50 | | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 34 | [SID49669839] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 35 | [SID49669839] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 36 | [SID49669839] | Inactive | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 37 | [SID49669839] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 38 | [SID49669839] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 39 | [SID49669839] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 40 | [SID49669839] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID49669839] | Inactive | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 42 | [SID49669839] | Inactive | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 43 | [SID49669839] | Inactive | | | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 [AID540277, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 | | AID | 540277 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 44 | [SID49669839] | Inactive | | | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 [AID540277, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1 | | AID | 540277 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 45 | [SID49669839] | Inactive | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 46 | [SID49669839] | Inactive | Potency | | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 47 | [SID49669839] | Inactive | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 48 | [SID49669839] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 49 | [SID49669839] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 50 | [SID49669839] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49669839 | | CID | 20923143 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|